Pmgc Holdings vs Korro Bio
Korro Bio is the larger business, with $6.4m of revenue in fiscal 2025 against $590,084 for Pmgc Holdings (10.8 times as much). Korro Bio grew faster (181.5% against -65.5%). Pmgc Holdings kept more of each dollar of sales as profit: a net margin of -1313.0% against -1834.5%.
| Latest fiscal year | Pmgc HoldingsELAB, 2025 | Korro BioKRRO, 2025 |
|---|---|---|
| Revenue | $590,084 | $6.4m |
| Revenue growth | -65.5% | 181.5% |
| Net income | −$7.7m | −$117m |
| Operating margin | — | — |
| Net margin | -1313.0% | -1834.5% |
| Return on equity | -132.8% | -110.7% |
| Free cash flow | −$6.4m | −$79.1m |
| Cash | $5.4m | $21.8m |
| Total debt | $1.4m | $0 |
| Debt to equity | 18.2% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 32 | 58 |
| Market value | $12.0m | $235m |
| Price vs our value range | — | — |
| Moat score | — | — |
| Insider trades, 12 months | 0 buys, 0 sales | 16 buys, 33 sales |